Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2022-09-08 Legal Proceedings Report
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
关于云南监管局行政监管措施决定书整改报告的公告
Legal Proceedings Report Classification · 95% confidence The document is a detailed announcement from a company about its rectification report in response to an administrative regulatory decision issued by the Yunnan Securities Regulatory Bureau. It discusses governance issues, internal control improvements, legal compliance, and measures taken to protect shareholder rights. The document is not a financial report, earnings release, or a simple announcement of a report publication. It is a regulatory compliance and legal proceedings update related to administrative measures and corrective actions. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length and content support this classification with high confidence.
2022-09-08 Chinese
2022年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the 2022 third extraordinary shareholders meeting of Yunnan Biological Valley Pharmaceutical Co., Ltd. It details the meeting date, location, attendance, agenda items, voting results, and legal opinions confirming the meeting's legality. The content focuses on shareholder meeting resolutions, including approval of stock repurchase plans and amendments to company bylaws. There is no financial data or report content, but rather the official announcement of voting results and meeting decisions. The document length is under 5,000 characters and it serves as an official announcement of shareholder meeting resolutions and voting outcomes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-09-08 Chinese
第四届监事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the sixth meeting of the fourth Supervisory Board of Yunnan Shengwu Gu Pharmaceutical Co., Ltd. It details the meeting's convening, attendance, and the approval of a corrective action report related to regulatory measures by the Yunnan Securities Regulatory Bureau. The document is an official announcement of a board/management decision rather than a full report or financial statement. It does not contain financial data or detailed management discussion but focuses on governance and compliance matters. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1151 characters), and it is not a report publication announcement or certification but a meeting resolution announcement.
2022-09-08 Chinese
关于收到北京证券交易所半年报问询函的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding receipt of an inquiry letter from the Beijing Stock Exchange about the company's half-year report. It contains detailed questions about the company's half-year financial performance, accounting treatments, and other operational matters. The document does not contain the half-year report itself but is a regulatory inquiry related to the half-year report. The document length is short (2801 characters) and it is an announcement of an inquiry, not the report or a certification. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2022-09-07 Chinese
前十大股东和前十大无限售条件股东情况公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement disclosing the top ten shareholders and top ten unrestricted shareholders as of a specific record date (September 2, 2022) in relation to a share repurchase plan to be voted on at an upcoming extraordinary general meeting. It includes detailed shareholder holdings but does not contain financial statements, management discussion, or other report content. The document is a regulatory disclosure related to shareholding information, specifically about major shareholders and share repurchase plans, but it is not a full report or financial statement. Given the content and purpose, this fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholder holdings, consistent with MRQ filings.
2022-09-04 Chinese
前十大股东和前十大无限售条件股东情况公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement disclosing the top ten shareholders and top ten unrestricted shareholders as of a specific date (August 19, 2022). It references a board meeting approving a share repurchase plan and states that the share repurchase plan will be submitted to a shareholders meeting. The document primarily provides shareholder information related to shareholding structure and share repurchase disclosures. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement related to shareholding and share repurchase plans. Therefore, the most appropriate classification is Major Shareholding Notification (MRQ), as it reports changes and details about significant share ownership levels and share repurchase plans.
2022-08-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.